How Effective Is Lyrica for Fibromyalgia Pain?
Lyrica (pregabalin) reduces fibromyalgia pain in many patients. FDA approved it in 2007 based on trials showing it lowers pain scores by 30% or more compared to placebo. In four pivotal 12- to 14-week studies with over 2,800 patients, 30-50% of those on 300-450 mg daily doses reported significant relief, versus 18-28% on placebo.[1][2] Average pain reduction was 2 points on a 10-point scale across trials.[3]
What Do Clinical Trials Show on Pain Scores?
Trials used the 0-10 numeric pain rating scale. Key results:
- One study (300-450 mg/day): 43% of patients had ≥30% pain reduction vs. 35% on placebo.
- Another (flexible dosing): 38% response rate vs. 27% placebo.
Effects start within 1-2 weeks, peak at 4-6 weeks. Lyrica also improved sleep, fatigue, and function via Patient Global Impression of Change scores.[1][4]
How Does It Compare to Placebo and Other Treatments?
Lyrica outperforms placebo by 10-20% in response rates across studies, with number needed to treat (NNT) of 11 for 30% relief (one patient benefits per 11 treated).[5] Versus duloxetine (Cymbalta), another fibromyalgia drug, Lyrica shows similar efficacy (38% vs. 40% response), but duloxetine edges on mood symptoms.[6] NSAIDs and opioids provide less consistent relief; guidelines favor pregabalin, duloxetine, or milnacipran first-line.[7]
Who Responds Best and What Dosage Works?
Best responders are women under 65 with moderate-to-severe baseline pain. Start at 150 mg/day (75 mg twice daily), titrate to 300-450 mg over 1 week. Higher doses yield more relief but increase side effects. About 1 in 3 patients discontinue due to dizziness or somnolence.[1][3]
What Limitations and Real-World Data Say
Trials lasted up to 6 months; long-term effectiveness wanes in some, with 20-30% losing response.[8] Real-world studies confirm 25-40% moderate relief, but 40% report no benefit.[9] Not all pain types respond equally—central sensitization in fibromyalgia drives its mechanism via calcium channel blockade in nerves.[10]
Common Side Effects and When It Fails
Dizziness (30%), somnolence (20%), weight gain (10%), and blurred vision occur most. Serious risks include angioedema or suicidal thoughts (black box warning).[2] It fails in patients with severe depression or if pain stems from inflammation rather than neuropathic components.
[1]: FDA Lyrica Label
[2]: Pfizer Lyrica PI
[3]: Crofford LJ et al. N Engl J Med 2005;352:1324-1331
[4]: Mease PJ et al. Pain 2008;136:419-431
[5]: Moore RA et al. Pain 2014;155:1743-1755
[6]: Hauser W et al. Pain 2011;152:2451-2464
[7]: MacFarlane GJ et al. Ann Rheum Dis 2017;76:318-325
[8]: Cooper TE et al. Cochrane Database Syst Rev 2017
[9]: Taylor CP et al. Curr Opin Investig Drugs 2007
[10]: DrugPatentWatch: Pregabalin Patents